EUVIMEDEUVIMED entdecken
Crossref

COVID-19, Type 2 Diabetes, and Hypogonadism: Lessons for Acute Management and Long-Term Prevention

Geoffrey Hackett, Michael Kirby

Androgens: Clinical Research and Therapeutics · 2020

DOI: 10.1089/andro.2020.0004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Androgens: Clinical Research and Therapeutics, 2020. Verfasst von Geoffrey Hackett und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 84 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hackett, G., & Kirby, M. (2020). COVID-19, Type 2 Diabetes, and Hypogonadism: Lessons for Acute Management and Long-Term Prevention. Androgens: Clinical Research and Therapeutics. https://doi.org/10.1089/andro.2020.0004

Vancouver

Hackett G, Kirby M. COVID-19, Type 2 Diabetes, and Hypogonadism: Lessons for Acute Management and Long-Term Prevention. Androgens: Clinical Research and Therapeutics. 2020. doi:10.1089/andro.2020.0004

BibTeX
@article{Hackett2020,
  author = {Hackett, Geoffrey and Kirby, Michael},
  title = {COVID-19, Type 2 Diabetes, and Hypogonadism: Lessons for Acute Management and Long-Term Prevention},
  journal = {Androgens: Clinical Research and Therapeutics},
  year = {2020},
  doi = {10.1089/andro.2020.0004}
}
Kostenlos starten →